ProSciento, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Chula Vista CA Uruguay (2004)

Organization Overview

First Clinical Trial
2010
NCT01201278
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hompesch, Marcus, M.D. | ProSciento | ProSciento, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Fatty Liver (Phase 2)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Overweight (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 8